Morgan Stanley has upgraded Clorox (NYSE:
CLX) from Underweight to Equal-Weight and maintains its $63 price target.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
